| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
From the Department of Pathology and Genetic Pathology Evaluation Centre,* Vancouver Hospital and Health Sciences Centre, University of British Columbia, Vancouver, British Columbia, Canada; the Departments of Pathology and Biochemistry, and the Howard Hughes Medical Institute, Stanford University School of Medicine, Stanford, California
Histological diagnosis of synovial sarcoma can be difficult. Genome-wide expression profiling has identified a number of genes expressed at higher levels in synovial sarcoma than in other soft tissue tumors, representing excellent candidates for diagnostic immunohistochemical markers. A tissue microarray comprising 77 sarcomas, including 46 synovial sarcomas, was constructed to validate identified markers and investigate their expression in tumors in the differential diagnosis of synovial sarcoma. Immunostaining was performed for two such markers, epidermal growth factor receptor and SAL (drosophila)-like 2 (SALL2), and for fifteen established markers used in the differential diagnosis of sarcomas. As predicted by expression profiling, epidermal growth factor receptor (a potential therapeutic target) and SALL2 stained most cases of synovial sarcoma; staining was significantly less common among other tested sarcomas. Hierarchical clustering analysis applied to immunostaining results for all 18 antibodies showed that synovial sarcomas, leiomyosarcomas, hemangiopericytomas, and solitary fibrous tumors cluster distinctly, and assigned one case with indeterminate histology as a Ewing sarcoma. Digital images from over 2500 immunostained cores analyzed in this study were captured and are made accessible through the accompanying website: http://microarray-pubs.stanford.edu/tma_portal/synsarc.
This article has been cited by other articles:
 |
|
 |
|
  W. Ren, B. Korchin, Q.-S. Zhu, C. Wei, A. Dicker, J. Heymach, A. Lazar, R. E. Pollock, and D. Lev Epidermal Growth Factor Receptor Blockade in Combination with Conventional Chemotherapy Inhibits Soft Tissue Sarcoma Cell Growth In vitro and In vivo Clin. Cancer Res., May 1, 2008; 14(9): 2785 - 2795. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 F. Bertucci, D. Birnbaum, and A. Goncalves Proteomics of Breast Cancer: Principles and Potential Clinical Applications Mol. Cell. Proteomics, October 1, 2006; 5(10): 1772 - 1786. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Y. Su, M. J. Shrubsole, R. M. Ness, Q. Cai, N. Kataoka, K. Washington, and W. Zheng Immunohistochemical Expressions of Ki-67, Cyclin D1, {beta}-Catenin, Cyclooxygenase-2, and Epidermal Growth Factor Receptor in Human Colorectal Adenoma: A Validation Study of Tissue Microarrays. Cancer Epidemiol. Biomarkers Prev., September 1, 2006; 15(9): 1719 - 1726. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C Kersting, J Packeisen, B Leidinger, B Brandt, R von Wasielewski, W Winkelmann, P J van Diest, G Gosheger, and H Buerger Pitfalls in immunohistochemical assessment of EGFR expression in soft tissue sarcomas J. Clin. Pathol., June 1, 2006; 59(6): 585 - 590. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. M. Fathallah-Shaykh Microarrays: Applications and Pitfalls Arch Neurol, November 1, 2005; 62(11): 1669 - 1672. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. Baird, S. Davis, C. R. Antonescu, U. L. Harper, R. L. Walker, Y. Chen, A. A. Glatfelter, P. H. Duray, and P. S. Meltzer Gene Expression Profiling of Human Sarcomas: Insights into Sarcoma Biology Cancer Res., October 15, 2005; 65(20): 9226 - 9235. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. A. Clark, C. Fisher, I. Judson, and J. M. Thomas Soft-Tissue Sarcomas in Adults N. Engl. J. Med., August 18, 2005; 353(7): 701 - 711. [Full Text] [PDF]
|
|
|
|
|
|
J. Terry, J. M. Lubieniecka, W. Kwan, S. Liu, and T. O. Nielsen Hsp90 Inhibitor 17-Allylamino-17-Demethoxygeldanamycin Prevents Synovial Sarcoma Proliferation via Apoptosis in In vitro Models Clin. Cancer Res., August 1, 2005; 11(15): 5631 - 5638. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. A. Ramos-Vara Technical Aspects of Immunohistochemistry Vet. Pathol., July 1, 2005; 42(4): 405 - 426. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Jacquemier, C. Ginestier, J. Rougemont, V.-J. Bardou, E. Charafe-Jauffret, J. Geneix, J. Adelaide, A. Koki, G. Houvenaeghel, J. Hassoun, et al. Protein Expression Profiling Identifies Subclasses of Breast Cancer and Predicts Prognosis Cancer Res., February 1, 2005; 65(3): 767 - 779. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. Woestenborghs, M. Debiec-Rychter, M. Renard, P. Demaerel, F. Van Calenbergh, S. Van Gool, and R. Sciot Cytokeratin-Positive Meningeal Peripheral PNET/Ewing's Sarcoma of the Cervical Spinal Cord: Diagnostic Value of Genetic Analysis International Journal of Surgical Pathology, January 1, 2005; 13(1): 93 - 97. [Abstract] [PDF]
|
|
|
|
|
|
T. O. Nielsen, F. D. Hsu, K. Jensen, M. Cheang, G. Karaca, Z. Hu, T. Hernandez-Boussard, C. Livasy, D. Cowan, L. Dressler, et al. Immunohistochemical and Clinical Characterization of the Basal-Like Subtype of Invasive Breast Carcinoma Clin. Cancer Res., August 15, 2004; 10(16): 5367 - 5374. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. M. Fathallah-Shaykh, B. He, L.-J. Zhao, and A. Badruddin Mathematical algorithm for discovering states of expression from direct genetic comparison by microarrays Nucleic Acids Res., July 20, 2004; 32(13): 3807 - 3814. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
